| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,765 | 0,820 | 09:41 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | Stocks in Play: Spectral Medical Inc. | 2 | Baystreet.ca | ||
| 07.08. | Spectral Medical Inc.: Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update | 1.243 | GlobeNewswire (Europe) | TORONTO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| SPECTRAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 25.06. | Spectral Medical Inc: Spectral Medical files FDA PMA for PMX sepsis therapy | 1 | Stockwatch | ||
| 25.06. | Spectral Medical Inc.: Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX | 244 | GlobeNewswire (Europe) | TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 09.06. | Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders | 450 | GlobeNewswire (Europe) | TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. "Spectral" or the "Company" (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 04.06. | Spectral Medical Inc: Spectral Medical talks Tigris top-line mortality data | 1 | Stockwatch | ||
| 04.06. | Stocks in Play: Spectral Medical Inc. | - | Baystreet.ca | ||
| 29.05. | Spectral Medical Inc: Spectral submits FDA PMA for PMX sepsis therapy.255 | 2 | Stockwatch | ||
| 29.05. | Spectral Medical Inc.: Spectral Medical Announces PMA Submission to U.S. FDA for PMX | 209 | GlobeNewswire (Europe) | TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 08.05. | Spectral Medical GAAP EPS of -$0.01, revenue of $891M | 2 | Seeking Alpha | ||
| 08.05. | Spectral Medical Inc.: Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update | 504 | GlobeNewswire (Europe) | PMA submission targeted for May 29, 2026 in alignment with FDAVantive commits to additional funding support ahead of PMA acceptance milestone TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical... ► Artikel lesen | |
| 01.04. | Bloom Burton & Co. Inc.: Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference | 609 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating... ► Artikel lesen | |
| 26.03. | Spectral Medical reports Q4 results | 1 | Seeking Alpha | ||
| 26.03. | Spectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update | 283 | GlobeNewswire (Europe) | TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 24.03. | Spectral Medical Inc: Spectral, Vantive release Tigris results in Lancet | 1 | Stockwatch | ||
| 24.03. | Spectral Medical Inc.: Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine | 411 | GlobeNewswire (Europe) | Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline... ► Artikel lesen | |
| 26.02. | Spectral Medical Inc.: Spectral Medical Provides Update on PMA Submission Timing for PMX-20R | 216 | GlobeNewswire (Europe) | TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 07.11.25 | Spectral Medical Inc.: Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update | 305 | GlobeNewswire (Europe) | PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,620 | +0,34 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| RHOEN-KLINIKUM | 14,600 | 0,00 % | 124 Nachwuchskräfte starten am RHÖN-KLINIKUM Campus Bad Neustadt in ihre berufliche Zukunft | Bad Neustadt a. d. Saale (ots) - Für 124 Nachwuchskräfte beginnt am RHÖN-KLINIKUM Campus Bad Neustadt ein neuer beruflicher Lebensabschnitt. In neun Gesundheits- und Verwaltungsberufen starten sie ihre... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,085 | -4,06 % | Stocks in Play: Sernova Biotherapeutics | ||
| FAMICORD | 2,880 | -1,37 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG
31.08.2026 / 14:30 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| M1 KLINIKEN | 21,350 | +0,23 % | EQS-News: M1 Kliniken AG veröffentlicht Halbjahresbericht 2026: Beauty-EBIT steigt um 23,8 % auf 18,6 Mio. EUR | EQS-News: M1 Kliniken AG
/ Schlagwort(e): Halbjahresbericht/Halbjahresergebnis
M1 Kliniken AG veröffentlicht Halbjahresbericht 2026: Beauty-EBIT steigt um 23,8 % auf 18,6 Mio.... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,440 | -1,21 % | Geratherm Medical Aktie: Der Umbau soll die Wende bringen | Geratherm Medical steckt operativ weiter in einer schwierigen Phase. Im ersten Halbjahr 2026 sank der Umsatz um 12,5 Prozent auf 7,0 Millionen Euro, während das EBIT auf minus 0,5 Millionen Euro zurückging.... ► Artikel lesen | |
| CERENOME | 1,958 | -5,64 % | Cerenome, Inc.: Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment | Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front | ||
| TENON MEDICAL | 5,340 | +0,75 % | Morning Market Movers: Tenon Medical, Shoe Station, Cooper Companies, Culp, Inc. See Big Swings | TOKYO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,760 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| AVEANNA HEALTHCARE | 13,860 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,370 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ADAPTHEALTH | 5,850 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| PROGYNY | 27,080 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| HEARTFLOW | 45,470 | -0,04 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen |